CLSD - Clearside Biomedical Q4 2023 Earnings Preview
2024-03-11 17:35:35 ET
More on Clearside Biomedical
- Clearside to sell 11.11M shares at $1.35 in registered direct offering
- Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical
- Financial information for Clearside Biomedical